Genomic Health Creates Clinical Genetics Subsidiary Called InVitae | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health has established a wholly owned subsidiary focused on providing clinical genetic services to doctors and patients.

In its Form 10-K dated March 14 and filed with the US Securities and Exchange Commission, the Redwood City, Calif.-based firm said the subsidiary, created earlier this month, is called InVitae and will begin offering services in 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.